Blueberries Medical Corp. (1OA)
XFRA 
Summary
1OA Chart
Blueberries Medical Corp. Dividends
Blueberries Medical Corp. Earnings
| 26 Aug 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 28 May 2025 Date | | - Cons. EPS | - EPS |
| 27 May 2025 Date | | - Cons. EPS | - EPS |
| 22 Nov 2024 Date | | - Cons. EPS | - EPS |
| 2 Sep 2024 Date | | - Cons. EPS | - EPS |
| 26 Aug 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 28 May 2025 Date | | - Cons. EPS | - EPS |
| 27 May 2025 Date | | - Cons. EPS | - EPS |
| 22 Nov 2024 Date | | - Cons. EPS | - EPS |
| 2 Sep 2024 Date | | - Cons. EPS | - EPS |
Blueberries Medical Corp. (1OA) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Blueberries Medical Corp. ever had a stock split?
Blueberries Medical Corp. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Facundo Garreton CEO | XFRA Exchange | CA09609Y1016 ISIN |
| Canada Country | - Employees | - Last Dividend | 4 Jul 2018 Last Split | - IPO Date |
Overview
Blueberries Medical Corp. is a burgeoning player in the global cannabis industry, primarily focused on the cultivation, growth, and development of medicinal cannabis along with its related products in Colombia. With its foundations firmly rooted in Vancouver, Canada, the company distinguishes itself through its strategic operations in Colombia, a country with an optimal climate and legislation supportive of cannabis cultivation. It targets both the psychoactive and non-psychoactive segments of the cannabis market, catering to a wide spectrum of medicinal needs with its diverse product offerings.
Products and Services
Blueberries Medical Corp. offers a comprehensive range of cannabis-based products, designed to meet various medical and therapeutic needs:
- Psychoactive Cannabis Products
- Non-Psychoactive Cannabis Products
These are derived from strains of cannabis that contain THC, the chemical responsible for most of marijuana's psychological effects. Such products are intended for therapeutic use in managing pain, stimulating appetite, and treating conditions like multiple sclerosis and glaucoma.
Centered around CBD, these products do not induce the "high" traditionally associated with cannabis use. They are highly sought after for their potential in treating anxiety, depression, seizures, and various inflammation-related conditions without psychoactive effects.
Contact Information
